R. E. Haddock

The effect of selective serotonin re‐uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes.

H.K. Crewe, MS Lennard, GT Tucker et al. · British Journal of Clinical Pharmacology · 1992 · 468 citations · Full text

Cytochrome P4502d6, Pharmacotherapy, Cyp2d6 Activity +22

The role of cytochrome P4502D6 in the metabolism of paroxetine by human liver microsomes.

JC Bloomer, F. R. Woods, R. E. Haddock et al. · British Journal of Clinical Pharmacology · 1992 · 132 citations · Full text

Cytochrome P4502d6, Molecular Biology, Toxicological Mechanism +17

Metabolic pathway of paroxetine in animals and man and the comparative pharmacological properties of its metabolites

R. E. Haddock, Margaret Johnson, P. F. Langley et al. · Acta Psychiatrica Scandinavica · 1989 · 94 citations

Pharmacological Study, Biochemistry, Comparative Pharmacological Properties +10

Metabolism of nabumetone (BRL 14777) by various species including man

R. E. Haddock, D. J. Jeffery, J. A. Lloyd et al. · Xenobiotica · 1984 · 75 citations

Sibutramine pharmacokinetics in young and elderly healthy subjects

I. D. Hind, J. E. Mangham, Sajda Ghani et al. · European Journal of Clinical Pharmacology · 1999 · 59 citations

Geriatrics, Pharmacology, Elderly Healthy Subjects +3